hydrocortisone 10mg tablets
mawdsley-brooks & company ltd - hydrocortisone - oral tablet - 10mg
hydrocortisone 10mg tablets
elara pharmaservices europe 239 blanchardstown corporate park, ballycoolin, dublin, d15 kv21, ireland - hydrocortisone - tablet - hydrocortisone 10 mg - corticosteroids for systemic use
hydrocortisone 20mg tablets
elara pharmaservices europe 239 blanchardstown corporate park, ballycoolin, dublin, d15 kv21, ireland - hydrocortisone - tablet - hydrocortisone 20 mg - corticosteroids for systemic use
hydrocortisone
douglas pharmaceuticals limited - hydrocortisone 20mg; - tablet - 20 mg - active: hydrocortisone 20mg excipient: lactose monohydrate magnesium stearate maize starch povidone purified talc
hydrocortisone
douglas pharmaceuticals limited - hydrocortisone 5mg; - tablet - 5 mg - active: hydrocortisone 5mg excipient: lactose monohydrate magnesium stearate maize starch povidone purified talc
hydrocortisone cream 1% (noumed)
noumed pharmaceuticals limited - hydrocortisone 1%{relative} (synthesis uses no animal materials); ; - topical cream - 1 % - active: hydrocortisone 1%{relative} (synthesis uses no animal materials) excipient: cetomacrogol 1000 cetostearyl alcohol chlorocresol liquid paraffin purified water white soft paraffin
hydrocortisone 1 % w/w cream
ovelle limited - hydrocortisone - cream - 1 percent weight/weight - corticosteroids, weak (group i); hydrocortisone
hydrocortisone 10 mg tablets
amdipharm limited - hydrocortisone - tablet - 10 milligram(s) - glucocorticoids; hydrocortisone
hydrocortisone 20 mg tablets
amdipharm limited - hydrocortisone - tablet - 20 milligram(s) - glucocorticoids; hydrocortisone
hydrocortisone tablet
carilion materials management - hydrocortisone (unii: wi4x0x7bpj) (hydrocortisone - unii:wi4x0x7bpj) - hydrocortisone 20 mg - hydrocortisone tablets are indicated in the following conditions. primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the first choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy mineralocorticoid supplementation is of particular importance) congenital adrenal hyperplasia non suppurative thyroiditis hypercalcemia associated with cancer as adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in: psoriatic arthritis rheumatoid arthritis, including juvenile rheumatoid arthritis (selected cases may require low-dose maintenance therapy) ankylosing spondylitis acute and subacute bursitis acute nonspecific tenosynovitis acute gouty arthritis post-traumatic osteoarthritis synovitis of osteoarthritis epicondylitis during an exacerbation or as maintenance therapy in selected cases of: systemic lupus erythematosus systemic dermatomyositis (polymyositis) acute rheumatic carditis pem